Table 1 |
||
|
Characterization of Atopic Patients Assessed (N = 72) |
||
| n (%) |
||
|
|
||
| Reason for referral |
||
|
|
||
| General allergy assessment |
34 (47) |
|
|
|
||
| Environmental allergies |
13 (18) |
|
|
|
||
| Rhinitis or sinusitis |
7 (10) |
|
|
|
||
| Anaphylactic event |
5 (7) |
|
|
|
||
| Rash or urticaria |
5 (7) |
|
|
|
||
| Food allergy |
4 (6) |
|
|
|
||
| Asthma |
4 (6) |
|
|
|
||
| Angioedema |
3 (4) |
|
|
|
||
| Cough |
3 (4) |
|
|
|
||
| Drug allergy |
2 (3) |
|
|
|
||
|
|
||
| Spirometry performed |
15 (21) |
|
|
|
||
| FEV1% <80% predicted |
3 (4) |
|
|
|
||
| FEV1/FVC % <75% predicted |
2 (13) |
|
|
|
||
|
|
||
| Other medications |
||
|
|
||
| HMG-CoA reductase inhibitor Iinhibitors inhibitors |
22 (31) |
|
|
|
||
| Diuretic |
19 (26) |
|
|
|
||
| ASA |
18 (25) |
|
|
|
||
| ACEi |
14 (19) |
|
|
|
||
| CCB |
10 (14) |
|
|
|
||
| Amitriptyline |
1 (1) |
|
|
|
||
| Cetirizine |
1 (1) |
|
|
ASA - acetyl salicylic acid, ACEi - angiotensin converting enzyme inhibitor, CCB - calcium channel blocker | ||
Fung and Kim Allergy, Asthma & Clinical Immunology 2010 6:2 doi:10.1186/1710-1492-6-2 |
||
